IVF comes with terminology that can feel more suited to a laboratory than an everyday conversation. One abbreviation couples may encounter is PGT-A, short for preimplantation genetic testing for aneuploidy. Put simply,  PGT-A testing is used to assess embryos created through IVF for certain chromosome-number abnormalities before decisions are made about embryo transfer.

For Indian men in their 20s and 30s, understanding the basics can make it easier to participate in fertility decisions rather than leaving every technical conversation to a partner. You do not need a genetics degree. You do, however, need to understand what the test examines, what it cannot tell you and why a specialist might -or might not -recommend it in a particular IVF journey.

First, What Are Chromosomes?

Chromosomes are structures within cells that contain genetic material. Humans typically have 46 chromosomes arranged in 23 pairs, although errors can occur during the formation of eggs, sperm or early embryo development.

An embryo with an abnormal number of chromosomes is described as aneuploid. Some chromosome abnormalities may prevent an embryo from implanting or developing normally, while others can be associated with miscarriage or particular genetic conditions.

The chance of chromosomal abnormalities in embryos generally increases with maternal age, although age alone cannot determine the chromosome status of an individual embryo.

That distinction matters: PGT-A does not simply label an embryo as “good” or “bad”. It provides specific genetic information that specialists interpret alongside other clinical factors.

How Does PGT-A Testing Work?

PGT-A forms part of an IVF process rather than being a standalone fertility test. Eggs are retrieved and fertilized in the laboratory. Embryos that continue developing may reach the blastocyst stage, usually several days after fertilization.

At an appropriate stage, a small number of cells can be carefully removed from the part of the blastocyst that typically develops into placental tissue. The sample is then analyzed to assess chromosome number.

The embryo is generally frozen while results are awaited. A fertility specialist can later discuss the findings and how they may affect decisions about which embryo to consider for transfer.

The exact laboratory methods and treatment sequence can vary, so couples should ask their clinic to explain its process rather than assuming every IVF center follows an identical protocol.

Why Might a Fertility Specialist Discuss PGT-A?

There is no single answer because recommendations should depend on individual circumstances.

A specialist may discuss PGT-A in relation to factors such as maternal age, previous IVF history, repeated pregnancy loss or other relevant clinical considerations. However, whether it offers a meaningful benefit in a particular case requires an individual assessment.

One important distinction is that testing embryos does not improve their chromosome status. Instead, it provides information about the sampled cells that may help inform embryo-selection decisions.

Couples should therefore ask a straightforward question: “What specific benefit do you expect this test to provide in our case?” The answer should relate to their medical circumstances rather than simply presenting testing as an automatic IVF add-on.

What Can -and Can’t -PGT-A Tell You?

Understanding limitations is just as important as understanding potential benefits.

PGT-A is designed primarily to assess chromosome-number abnormalities. It is not a comprehensive guarantee that an embryo has no genetic or developmental problems, nor can it guarantee implantation, pregnancy or the birth of a healthy baby.

Results can also be more complicated than a simple normal-versus-abnormal classification. In some situations, testing may produce a mosaic result, indicating that the sampled cells contain a mixture of chromosomal findings. There may also be inconclusive results.

This is why PGT-A testing requires professional interpretation. Couples who receive complex results may benefit from detailed counselling with their fertility specialist and, where appropriate, a genetics professional.

Is Embryo Biopsy Completely Risk-Free?

Any laboratory procedure involving an embryo deserves a clear discussion of potential risks and limitations.

Modern embryo biopsy techniques are carefully performed by trained professionals, but no medical or laboratory procedure should casually be described as having zero risk. Ask your specialist about the clinic’s biopsy process, laboratory experience and what happens if a sample does not produce a clear result.

It is also worth asking about the freezing and thawing process because embryos undergoing PGT-A are commonly cryopreserved while results are processed.

Rather than focusing on one procedure in isolation, try to understand the complete sequence from embryo development and biopsy to freezing, results and possible transfer.

What Should Men Ask During the Consultation?

Fertility appointments can easily become one-sided, particularly when much of the physical treatment is happening to the female partner. Male partners can still play an active role.

Start with practical questions. Why is PGT-A being suggested? How many embryos might realistically be available for testing? What kinds of results can come back? How could each result affect the transfer plan? What additional costs and time could be involved?

Also ask whether your own medical or reproductive history requires further assessment. IVF is a couple-based process, and sophisticated embryo testing should not distract from relevant evaluation of both partners.

Take notes during the appointment. Medical terminology can blur together after 30 minutes, especially when you are also thinking about work calls, traffic and treatment schedules.

Planning Treatment Around India’s Festive Season

IVF calendars do not always cooperate with social calendars. Diwali, Christmas and India’s winter wedding season can mean packed weekends, family travel and late nights precisely when appointments need to happen.

If PGT-A testing is being incorporated into an IVF cycle, ask for an approximate timeline early. Understand when egg retrieval may occur, when embryo development and biopsy are expected, when results might be available and when a subsequent transfer could potentially be considered.

Avoid booking non-refundable travel based on an assumed treatment date. Biology and clinical decisions can shift timelines.

Comfort also helps on long clinic days. Think relaxed trousers, breathable tees or shirts and supportive footwear rather than restrictive formal clothes. During North Indian winters, removable layers work well for moving between chilly mornings, warm cars and temperature-controlled clinics.

Keep Fitness Sensible During a Treatment Cycle

If training is a major part of your routine, fertility treatment does not necessarily mean abandoning healthy habits. But it is a poor time to experiment with aggressive diets, unverified supplements or performance-enhancing substances.

Men should tell their doctor about medications, supplements, testosterone or anabolic steroid use because some substances can affect reproductive health.

Your partner may also receive specific instructions about exercise at different stages of IVF. Follow the treating team’s guidance rather than assuming a shared gym routine remains appropriate throughout ovarian stimulation, retrieval and recovery.

The goal during treatment is consistency, not setting personal records.

How Should You Think About Success Rates?

Numbers can become misleading when they are stripped of context. If a clinic discusses success rates associated with PGT-A, ask exactly what outcome is being measured.

Is the percentage referring to implantation per embryo transfer, clinical pregnancy, miscarriage, live birth, or another endpoint? Does the data apply to patients of a similar age and medical profile?

Also ask whether the comparison is being made per transfer or across an entire treatment cycle. Different ways of presenting statistics can produce very different impressions.

A useful consultation should help you understand probabilities without suggesting certainty.

Conclusion: Information Should Support the Decision

PGT-A testing can provide information about the chromosome number of embryos created during IVF, but it is a screening tool with specific capabilities and limitations -not a guarantee of pregnancy or a healthy baby.